linea guida Archivi - Pagina 3 di 7 - SIMPIOS

SHEA/IDSA/APIC Practice Recommendation: Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute-care hospitals: 2022 Update

ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Cl Microb Infect, 2014

OMS (traduzione Ministero dela Salute) Linee guida per la prevenzione e il controllo di Enterobatteri, Acinetobacter baumannii e Pseudomonas aeruginosa resistenti ai carbapenemi nelle strutture sanitarie. 2017 (traduzione 2020)

Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control (2017)

Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. WHO, 2017

Implementation manual to prevent and control the spread of carbapenem-resistant organisms at the national and health care facility level. WHO, 2019

Guidelines for the Prevention and Control of Multi-drug resistant organisms (MDRO) excluding MRSA in the healthcare setting. Ireland, 2012

Framework of actions to contain carbapenemase-producing Enterobacterales. UK Health Security Agency, Septembre 2022

GUIDELINE FOR PREVENTION OF CATHETERASSOCIATED URINARY TRACT INFECTIONS 2009. HICPAC CDC, 2009

SHEA/IDSA/APIC. Strategies to prevent catheter-associated urinary tract infections in acute-care hospitals: 2022 Update